Clinton McCracken is a Senior Medical Manager with LEO Pharma Canada.
Friday NOV 25, 2022
The case at hand: the chronic hand eczema landscape in 2022
Chronic hand eczema can have a severe impact on quality of life. Although there has been a paucity of approved therapies focused on this condition, there have recent updates to international guidelines and there are a variety of ongoing clinical development programs investigating new treatments. This session will review disease background and burden, the latest guideline updates, and briefly discuss emerging therapies to ensure attendees have the most current information on chronic hand eczema management.
- Review the definition, incidence, and disease burden of chronic hand eczema, highlighting the impact on both patients and to society
- Describe the latest guideline updates related to the prevention and management of chronic hand eczema
- Discuss treatment options and the potential future treatment landscape in light of currently available data